CAM
IMVT icon

ClariVest Asset Management’s Immunovant IMVT Stock Holding History

ClariVest Asset Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$405K Hold
15,334
– – 0.04% 362
2024
Q2 		$405K Sell
15,334
-29
-0.2% -$825 0.04% 362
2024
Q1 		$496K Buy
15,363
+16
+0.1% +$584 0.05% 359
2023
Q4 		$647K Sell
15,347
-6,030
-28% -$222K 0.04% 335
2023
Q3 		$821K Hold
21,377
– – 0.04% 269
2023
Q2 		$406K Sell
21,377
-1,600
-7% -$29.8K 0.02% 361
2023
Q1 		$356K Buy
+22,977
New +$399K 0.02% 406

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

ClariVest Asset Management's IMVT Position: Q3 2024 in Review

ClariVest Asset Management held its Immunovant (IMVT) position steady in Q3 2024 at 15,334 shares worth $405K. The position accounts for 0.04% of the portfolio, ranked #362.

ClariVest Asset Management first reported a position in IMVT in Q1 2023 and has held it in 7 quarters since. The position peaked at $821K in Q3 2023. 181 funds tracked by Wall St. Rank hold IMVT as of Q3 2024.

  • ClariVest Asset Management held 15,334 shares of Immunovant worth $405K as of Q3 2024.
  • ClariVest Asset Management left its Immunovant share count unchanged in Q3 2024.
  • Immunovant made up 0.04% of ClariVest Asset Management's portfolio in Q3 2024, its #362 holding.
  • ClariVest Asset Management first reported a position in Immunovant in Q1 2023 and has held it in 7 quarters since.
  • ClariVest Asset Management's Immunovant position peaked at $821K in Q3 2023.
  • 181 funds tracked by Wall St. Rank held Immunovant as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.